Evidence map›Paper›PMID 35248000›Full record

ArticleBMC public health2022

A qualitative descriptive study of providers' perspectives on human papillomavirus vaccine administration among Latino/a adolescents in South Texas clinics: barriers and facilitators.

Daisy Y Morales-Campos, Bertha E Flores, Erin Donovan, Suzanne Burdick, Deborah Parra-Medina, Jessica A Kahn

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMC public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05419232 (RADx Up Safe Return to Schools), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05419232 nacompletednot on this map

RADx Up Safe Return to Schools: Strategies to Increase Vaccine Uptake

TypeinterventionalSponsorWashington University School of MedicineRan2022 to 2024Enrolled262ConditionsVaccination Refusal, COVID-19ArmsShort Message Service (SMS) + Website Link Strategy, Phone Call with Peer Strategy
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Effect of Initiating HPV Vaccination Before Age 11 on HPV Vaccination Completion.Journal of the American Board of Family Medicine : JABFM · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Daisy Y Morales-CamposLatino Research Institute, The University of Texas at Austin, 210 W. 24th Street, GWB 1.102C, F9200, Austin, TX, 78712, USA. moralescampos@austin.utexas.edu.
Bertha E FloresSchool of Nursing, UT Health San Antonio, San Antonio, USA.
Erin DonovanDepartment of Communication Studies, The University of Texas at Austin, Austin, USA.
Suzanne BurdickDepartment of Communication Studies, The University of Texas at Austin, Austin, USA.
Deborah Parra-MedinaLatino Research Institute, The University of Texas at Austin, 210 W. 24th Street, GWB 1.102C, F9200, Austin, TX, 78712, USA.
Jessica A KahnCincinnati Children's Hospital Medical Center and the Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, USA.
The University of Texas at Austin · USThe University of Texas Health Science Center at San Antonio · USUniversity of Cincinnati · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSouth Texas Latinas experience higher cervical cancer incidence and mortality compared to Latinas nationwide. Despite the availability of effective human papillomavirus vaccines, South Texas Latino/a adolescents sub-optimally complete the series. Research shows provider recommendation strongly predicts vaccine uptake, but minority adolescents are less likely to report that their provider recommended the vaccine and series completion. There is also scant information on the HPV vaccine administration process in clinic practices providing vaccination services to Latino adolescents with limited access to healthcare resources. The purpose of the study was to describe providers' experience with administering the HPV vaccine to Latino/a patients in their practices.

methodsThe study used qualitative description to describe the experience of 15 South Texas healthcare providers (doctors and nurses) with the process of HPV vaccine administration in their practices. We conducted open ended, audio-recorded interviews, which were subsequently transcribed verbatim and uploaded into Atlas.(ti) 7.0 for analysis. The interviews yielded detailed descriptions of barriers and facilitators that could potentially impact HPV vaccine uptake.

resultsProviders identified parental exposure to provider recommendation as enhancing HPV acceptance and existing policies and implementation of evidence-based practices as facilitators of HPV vaccine uptake. Barriers ranged from parental fears of adolescent sexual activity and potential vaccine side effects to lack of transportation and the cost of the vaccine.

conclusionThese findings reflect barriers and facilitators to administering the HPV vaccine previously identified and also highlight issues unique to the situation among Latinos in South Texas. Implications include the need to design and implement efforts to improve provider-parent communication and enhance parental and adolescent patients' understanding of and confidence in the HPV vaccine. Furthermore, policy changes are needed to rectify organizational/structural challenges to HPV vaccine administration.

Indexed as

Papillomavirus InfectionsPapillomavirus VaccinesAdolescentHealth Knowledge, Attitudes, PracticeHispanic or LatinoHumansPatient Acceptance of Health CareTexasVaccinationPapillomavirus VaccinesCancer preventionHealthcare providersHPV vaccinationLatino adolescentsQualitative description

Identifiers

PMID35248000
PMCPMC8897614
OpenAlexW4221133400

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.